Genfoquest Analytica Logo

    Genfoquest Analytica

    Innovative solutions for data-driven life sciences

    We Simplify Bioinformatics for You

    Who we are

    Genfoquest Analytica (GQA) is a big data analytics company with a specific focus on bioinformatics. Founded in 2022 at Ege Teknopark, Izmir, Türkiye, we are dedicated to democratizing multi-omics insights through fast, scalable bioinformatics solutions.

    Our core expertise lies in AI-powered software for transcriptomics, single-cell analysis, and drug discovery. We process large-scale omics data, enabling biomarker discovery via cell atlas generation.

    90%
    Genetics Focus
    80%
    Big Data
    60%
    Machine Learning
    Genfoquest Analytica - Innovative solutions for data-driven life sciences

    Unlocking genomic insights

    From individual sequences to population-level haplotypes, our bioinformatics pipelines extract meaningful patterns from complex genomic data.

    DNA Sequence Analysis - From individual sequences to haplotypes

    What we provide

    End-to-end workflow engineering for specialized molecular data structures

    Data Curation & Quality Control

    Standard data quality control procedures and curation for downstream analysis.

    Comprehensive Data Validation
    Batch Effect Analysis
    Noise Reduction Techniques
    Reliable Normalization Strategies

    Data Analytics & Interpretation

    Standard or customized analysis pipelines for your research needs.

    Advanced Mutation Detection
    Gene Expression Profiling
    Whole Genome Assembly
    Multi-Omics Integration

    Machine Learning & AI

    Advanced predictive models and pattern recognition for genomic insights.

    Virtual Compound Screening
    Drug Target Identification
    3D Protein Structure Analysis
    Biomarker Discovery

    Consulting & Experience Exchange

    We are always with you on your project, providing expert guidance.

    Experimental Design Optimization
    Cost and Resource Estimation
    Result Interpretation Guidance
    Biological Insight Discovery

    Our software solutions

    Purpose-built software architecture for precision task management

    Smart Bioinformatics Interface (SBI)

    Software completed • User tests active

    Enterprise-grade bioinformatics solution used by leading pharmaceutical companies including Boehringer Ingelheim.

    Processed over 2TB of data for 1M+ cell RNA-seq atlas

    Single Cell Quest (SCQ)

    Online platform completed • Ready for cloud

    Your personalized bioinformatics space for single-cell analysis. Submit analysis tasks, monitor progress, and collaborate with colleagues.

    Available at scq.genfoquest.com

    Visit platform

    Prostatistix

    Active development

    Specialized analytics for prostate cancer research and biomarker discovery.

    Coming soon

    mAb-Target Affinity

    Analysis pipeline completed

    Monoclonal antibody target affinity assessment with off-target risk analysis.

    Off-target assessment in development

    Our analytica portfolio

    Gene Set Enrichment Analyses
    Copy Number Variant Analysis
    Genome Wide Association Studies (GWAS)
    Single Cell RNAseq
    Single Cell ATACseq
    Spatial Single Cell Transcriptomics
    Methylation Analysis
    Genomics & Transcriptomics Analysis

    Trusted by global pharma leaders

    Our workflows are used by leading pharmaceutical companies. We enabled Boehringer Ingelheim to build a single-cell RNA-seq atlas of over 1 million cells, processing over 2TB of data to uncover age-related macular degeneration (AMD) biomarkers.

    Information security policyGDPR compliantInternational standards

    Leadership

    Yasin Kaymaz, PhD

    Yasin Kaymaz, PhD

    Co-founder & Scientific Director

    Ph.D. from UMass Medical School (2017), specializing in transcriptome analysis, mutation profiling, and NGS technologies. Former Bioinformatics Scientist at Harvard University developing analytical methods for single-cell RNA sequencing. Currently faculty member in Bioengineering at Ege University, leading the Bioinformatics and Molecular Genetics Laboratory.

    yasinkaymaz@genfoquest.com
    Talha Güler, PhD

    Talha Güler, PhD

    Co-founder & Managing Director

    Seasoned executive with 18 years of experience in medical device and IVD sectors. Proven track record in developing strategic initiatives and leading cross-functional teams. Career highlights include key roles at Johnson & Johnson, Becton Dickinson, and Managing Director at Technogen.

    talhaguler@genfoquest.com

    Scientific advisory board

    Our bioinformatics technologies are supported by leading scientists in the community

    Manuel Garber

    UMass Medical School, USA

    Jeffrey Bailey

    Brown University, USA

    Alper Kuclikural

    UMass Medical School, USA

    Ann Moormann

    UMass Medical School, USA

    Timothy Sackton

    Harvard University, USA

    Ozkan Aydemir

    UMass Medical School, USA

    Collaborative projects with Vivosel

    Partnering with Vivosel for cutting-edge CAR-T cell development and off-target risk assessment for cancer therapies.

    Lung Cancer CAR-T

    Candidate selection and off-target risk assessment using in silico tests by GQA.

    CD19 CAR-T Development

    Computer-aided scFv design with Vivosel & Genfoquest Analytica collaboration.

    Get in touch

    Ready to unlock insights from your genomic data? Contact us for a free consultation and quote.

    +90-232-311-5860info@genfoquest.comEge Teknopark, Izmir, Türkiye